Research – Potsdam Science Park

13.12.21

Fighting cancer with alpacas — Interview with Dr Oren Moscovitz

At the Max Planck Institute of Colloids and Interfaces in the Potsdam Science Park, Dr. Oren Moscovitz (Group Leader Biomolecular Systems) is researching novel antibodies to develop valuable new tools that target specific glycan structures on our cell membranes and help fight cancer. To do this, he receives special help from – Alpacas. Very likely,…

13.12.21

A new Ear towards the Universe — Dr Kenta Kiuchi on his work

Since 2019 Dr. Kenta Kiuchi has been a group leader in the Numerical and Relativistic Astrophysics department at the Max Planck Institute for Gravitational Physics (Albert Einstein Institute) in the Potsdam Science Park. Using complex simulations, he helps other researchers to detect gravitational waves of colliding neutron stars – and thus listen to the universe…

20.8.21

“Our Technology for the Production of Antibodies is a kind of Turbocharger” – Interview with Prof. Katja Hanack

Katja Hanack is Professor of Immunotechnology at the University of Potsdam and is among the most renowned scientists worldwide in the field of research into antibodies. Thanks to her intensive research, she is now able to offer a comprehensive and innovative technology portfolio with which to produce antibodies quickly and effectively. With the aid of…

13.8.21

Insight into the development of the Respiratory Mask with an Integrated Corona Test – with Dr. Cornelia Hettrich

Corona tests are an important component of the measures aimed at containing the spreading of SARS-CoV-2. The standard test procedures do have their disadvantages, however. In a joint project between Fraunhofer IZI-BB and Fraunhofer IAP, a team headed by Dr. Cornelia Hettrich is working on possibilities to make a test procedure possible without the need…

6.8.21

“The Next Generation of Protective Textiles”: Respiratory masks that kill off Corona viruses and are washable – Dr. Katja Uhlig

Respiratory masks could soon be experiencing a minor revolution: it is said that, in the foreseeable future, they will kill off viruses on their surfaces already and be washable at 40°C. It is on this precise aspect that Dr. Katja Uhlig and Dr. Sebastian Kersting of Fraunhofer IZI-BB and Dr. Erik Wischerhoff of Fraunhofer IAP…

30.7.21

“If everything goes well, a drug against COVID-19 could be on the market in a few years based on our research.” — Interview with Dr Ruben R. Rosencrantz

In the Potsdam Science Park, institutes and companies are working on treatments and solutions to further contain the spread of coronavirus or to accelerate the cure. Dr Ruben R. Rosencrantz heads the “Life Science and Bioprocesses” research area and the “Biofunctionalised Materials and (Glyco)Biotechnology” department at the Fraunhofer Institute for Applied Polymer Research IAP. The…